ANIMA Trial
Cross-source consensus on ANIMA Trial from 1 sources and 6 claims.
1 sources · 6 claims
Risks & contraindications
Evidence quality
Where it comes from
Other
Other
Other
Highlighted claims
- The ANIMA study is a prospective randomized controlled parallel-group pilot trial with 1:1 allocation. — Study protocol for testing a mobile app designed to improve health literacy and self-management in people with bronchiectasis: the ANIMA app
- The trial is conducted at Hospital das Clínicas, Universidade Estadual de Campinas, in Campinas, São Paulo, Brazil. — Study protocol for testing a mobile app designed to improve health literacy and self-management in people with bronchiectasis: the ANIMA app
- The trial is designed mainly to assess feasibility, adherence, data completeness, usability, and effect size estimates rather than definitive efficacy. — Study protocol for testing a mobile app designed to improve health literacy and self-management in people with bronchiectasis: the ANIMA app
- Participants are allocated using sealed opaque envelopes prepared by an independent researcher. — Study protocol for testing a mobile app designed to improve health literacy and self-management in people with bronchiectasis: the ANIMA app
- Recruitment began in April 2025 and was planned to continue until October 2025, with final follow-up expected by April 2026. — Study protocol for testing a mobile app designed to improve health literacy and self-management in people with bronchiectasis: the ANIMA app
- Blinding is not feasible and the study acknowledges possible detection bias. — Study protocol for testing a mobile app designed to improve health literacy and self-management in people with bronchiectasis: the ANIMA app